This technical guideline outlines the concept of drug requirements planning, tiered drug planning practices from the health care facility level to the national level, as well as monitoring and evaluation including key indicators in drug requirements planning. It is hoped that through the implementation of this technical guideline, the availability, equity and affordability of drugs, as well as improving the quality of drug management can be achieved.